Clinical Studies 2 patients treated last week in our new clinical study site OLVG! Mar 15, 2023 HeleneCardiawave 0
Clinical Studies 20 patients treated in our on-going European Valvosoft® Pivotal Study ! Feb 27, 2023 HeleneCardiawave 0
Press Release Cardiawave granted 3 new patents extending its intellectual property protection for its technology in the United States Feb 14, 2023 HeleneCardiawave 0
About Us Nous sommes fiers d’annoncer que Cardiawave vient de devenir membre de la French Care ! Jan 26, 2023 HeleneCardiawave 0
Events Journées Européennes de la SFC 2023 (cardio-online) Jan. 11-13 – Paris Jan 11, 2023 HeleneCardiawave 0
Clinical Studies2 patients treated last week in our new clinical study site OLVG! Mar 15, 2023 READ MORE
Clinical Studies20 patients treated in our on-going European Valvosoft® Pivotal Study ! Feb 27, 2023 READ MORE
Press ReleaseCardiawave granted 3 new patents extending its intellectual property protection for its technology in the United States Feb 14, 2023 READ MORE
About UsNous sommes fiers d’annoncer que Cardiawave vient de devenir membre de la French Care ! Jan 26, 2023 READ MORE
EventsSNITEM : 10èmes rencontres du progrès médical le 13 décembre 2022 à l’Institut Pasteur Dec 7, 2022 READ MORE
About UsThe entire team is pleased and proud to have obtained the renewal of the EN ISO 13485: 2016 certification ! Nov 22, 2022 READ MORE
Clinical Studies 2 patients treated last week in our new clinical study site OLVG! Mar 15, 2023 HeleneCardiawave 0
Clinical Studies 20 patients treated in our on-going European Valvosoft® Pivotal Study ! Feb 27, 2023 HeleneCardiawave 0
Press Release Cardiawave granted 3 new patents extending its intellectual property protection for its technology in the United States Feb 14, 2023 HeleneCardiawave 0
About Us Nous sommes fiers d’annoncer que Cardiawave vient de devenir membre de la French Care ! Jan 26, 2023 HeleneCardiawave 0
Events Journées Européennes de la SFC 2023 (cardio-online) Jan. 11-13 – Paris Jan 11, 2023 HeleneCardiawave 0
